Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 254

Sort by

Sort Order Select

Journal Articles

Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders

Blood (2021) 137 (26): 3660–3669.

https://doi.org/10.1182/blood.2020009810

Published: 2021

Includes: Supplemental data

Journal Articles

Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation

Blood (2021) 137 (17): 2394–2402.

https://doi.org/10.1182/blood.2020008997

Published: 2021

Includes: Supplemental data

Journal Articles

“OMICs” reveal the molecular basis of a rare blood group

John D. Schuetz

Blood (2020) 135 (6): 396–397.

https://doi.org/10.1182/blood.2019004603

Published: 2020

Journal Articles

Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation

Blood (2020) 135 (6): 441–448.

https://doi.org/10.1182/blood.2019002320

Published: 2020

Includes: Supplemental data

Journal Articles

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Veysel Suzan, MD, Nurgul Ozgur Yurttas, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Isil Erdogan, MD, Tugrul Elverdi, MD, Ayse Salihoglu, MD, Muhlis Cem Ar, MD PhD, Zafer Baslar, MD

Blood (2019) 134 (Supplement_1): 4933.

https://doi.org/10.1182/blood-2019-130305

Published: 2019

Journal Articles

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

Linduarte Varela Morais, Aldair Sousa Paiva, PhDMD, Valéria SF Sales, PhD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2019) 134 (Supplement_1): 4990.

https://doi.org/10.1182/blood-2019-123802

Published: 2019

Journal Articles

ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh

Ghaydaa Juma Kullab, MD, Abdul Rehman Z. Zaidi, MBBS, Sultan Albaqmi, Haya Alajlan, Mohammed Abdullah Alsheef, MD

Blood (2019) 134 (Supplement_1): 4926.

https://doi.org/10.1182/blood-2019-128050

Published: 2019

Journal Articles

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

Hanne Rozema, MSc, Robby Kibbelaar, Dr., Nic Veeger, Dr., Mels Hoogendoorn, Dr., Eric van Roon, Prof. Dr.

Blood (2019) 134 (Supplement_1): 4253.

https://doi.org/10.1182/blood-2019-123357

Published: 2019

Journal Articles

KIR-Genotype Mismatch, Donor KIR Locus 3DS1 Positive or 2DS3 Negative Facilitates a Positive Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study of 74 Patients

Yu Zhang, Shaozhen Chen, Jinhua Ren, Xiaofeng Luo, Jianda Hu, PhD, Ting Yang

Blood (2019) 134 (Supplement_1): 5736.

https://doi.org/10.1182/blood-2019-127819

Published: 2019

Journal Articles

Ex vivo Engineering of Red Blood Cells

Jan Frayne, BsC, PhD, Deborah E Daniels, Jan Frayne, BsC PhD, Timothy J Satchwell, PhD, Joseph Hawksworth, BSc PhD, Belinda K Singleton, Tatyana N Andrienko, PhD, Marieangela C Wilson, Sabine Kupzig, Marjolein Meinders, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, Ivan Ferrer Vicens, PhD MSc, BSc, Rebecca Griffiths, PhD, Nicola Cogan, Kongtana Trakarnsanga, MD PhD, David J. Anstee, PhD FRCPath, Ashley Mark Toye, PhD

Blood (2019) 134 (Supplement_1): SCI-5.

https://doi.org/10.1182/blood-2019-121117

Published: 2019

Journal Articles

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Judit Rejtoe, MD, Oliver Königsbrügge, MD, Ella Grilz, MD, Stefanie Hofer, Johanna Gebhart, MD, Gerhard Schuster, MD, Clemens Feistritzer, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2019) 134 (Supplement_1): 1135.

https://doi.org/10.1182/blood-2019-123187

Published: 2019

Journal Articles

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

Jorn Gerritsma, MD, Ilja Oomen, BSc, Sanne Meinderts, PhD, C. Ellen van der Schoot, MD PhD, Bart J. Biemond, MD PhD, Johanna G van der Bom, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2019) 134 (Supplement_1): 2459.

https://doi.org/10.1182/blood-2019-128199

Published: 2019

Journal Articles

Identification of Novel Variants Associated with Fetal Hemoglobin Levels in Healthy Donors (the INTERVAL study)

Emily Kawabata, Samuel Lessard, PhD, Dirk Paul, Paola G Bronson, Robert Peters, Sriram Krishnamoorthy, PhD, William Astle, Adam Butterworth

Blood (2019) 134 (Supplement_1): 2243.

https://doi.org/10.1182/blood-2019-123977

Published: 2019

Journal Articles

Novel Conditioning Regimen for Haploidentical Hematopoietic Cell Transplant for Severe Aplastic Anemia in Children

Hasan Hashem, MD, Rawad Rihani, MBBS, MD, Eman Khattab, MD, Mayada Abu Shanap, MD, Abdelghani Tbakhi, MD, Iyad Sultan, MD

Blood (2019) 134 (Supplement_1): 5651.

https://doi.org/10.1182/blood-2019-126620

Published: 2019

Journal Articles

The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System

Blood (2019) 134 (Supplement_1): 715.

https://doi.org/10.1182/blood-2019-124082

Published: 2019

Journal Articles

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

Christina Evans, MPH,MD, Ching-Png Hong, Aaron R Folsom, MD, Susan Heckbert, MD PhD, Nicholas Smith, PhD, Kerri Wiggins, MS, Mary Cushman, MD

Blood (2019) 134 (Supplement_1): 1151.

https://doi.org/10.1182/blood-2019-131290

Published: 2019

Journal Articles

Blood group genotyping

Connie M. Westhoff

Blood (2019) 133 (17): 1814–1820.

https://doi.org/10.1182/blood-2018-11-833954

Published: 2019

Journal Articles

Increased galactose expression and enhanced clearance in patients with low von Willebrand factor

Sonia Aguila, Michelle Lavin, Niall Dalton, Sean Patmore, Alain Chion, George D. Trahan, Kenneth L. Jones, Catriona Keenan, Teresa M. Brophy, Niamh M. O’Connell, Kevin Ryan, Mary Byrne, Margaret Nolan, Anjali Patel, Roger J. S. Preston, Paula James, Jorge Di Paola, Jamie M. O’Sullivan, James S. O’Donnell

Blood (2019) 133 (14): 1585–1596.

https://doi.org/10.1182/blood-2018-09-874636

Published: 2019

Includes: Supplemental data

Journal Articles

Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function

Eimear Dunne, Qin M. Qi, Eric S. Shaqfeh, Jamie M. O’Sullivan, Ingmar Schoen, Antonio J. Ricco, James S. O’Donnell, Dermot Kenny

Blood (2019) 133 (12): 1371–1377.

https://doi.org/10.1182/blood-2018-06-855528

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis

Lova Sun, MD, Johnathan P. Mack, MD, Ang Li, MD, Justine Ryu, MD, Vivek A Upadhyay, MD, Robert Makar, MD PhD, Pavan Bendapudi, MD

Blood (2018) 132 (Supplement 1): 375.

https://doi.org/10.1182/blood-2018-99-110656

Published: 2018

NARROW

Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders

Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation

“OMICs” reveal the molecular basis of a rare blood group

Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

KIR-Genotype Mismatch, Donor KIR Locus 3DS1 Positive or 2DS3 Negative Facilitates a Positive Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study of 74 Patients

Ex vivo Engineering of Red Blood Cells

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

Identification of Novel Variants Associated with Fetal Hemoglobin Levels in Healthy Donors (the INTERVAL study)

Novel Conditioning Regimen for Haploidentical Hematopoietic Cell Transplant for Severe Aplastic Anemia in Children

The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

Blood group genotyping

Increased galactose expression and enhanced clearance in patients with low von Willebrand factor

Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only